Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
116.57
+0.85 (0.73%)
At close: Sep 25, 2026, 4:00 PM EDT
115.37
-1.20 (-1.03%)
After-hours: Sep 25, 2026, 7:47 PM EDT
Veradermics Employees
Veradermics had 37 employees as of June 30, 2026.
Employees
37
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,818,649
Market Cap
4.87B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 37 | - | - |
| Mar 31, 2026 | 24 | - | - |
| Dec 31, 2025 | 21 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Iovance Biotherapeutics | 975 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Cogent Biosciences | 258 |
| Tango Therapeutics | 137 |
| Edgewise Therapeutics | 127 |
| Definium Therapeutics | 106 |
MANE News
- 12 days ago - Citi opens ‘upside 90-day catalyst watch’ on Veradermics into data - TheFly
- 17 days ago - Veradermics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 18 days ago - Veradermics Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 24 days ago - Veradermics to Present at Upcoming September Investor Conferences - Business Wire
- 6 weeks ago - Veradermics Earnings release: Q2 2026 - Filings
- 6 weeks ago - Veradermics Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Veradermics sees cash runway into 2030 - TheFly
- 6 weeks ago - Veradermics reports Q2 net loss ($23.5M) vs. ($15.6M) last year - TheFly